March 23, 2018 / 12:34 PM / a month ago

BRIEF-Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Posts ‍FY Profit Attributable Of RMB75.3 Million

March 23 (Reuters) - Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd:

* ‍FY REVENUE RMB497.7 MILLION VERSUS RMB621.9 MILLION

* ‍FY PROFIT ATTRIBUTABLE RMB75.3 MILLION VERSUS RMB138.7 MILLION​

* BOARD RECOMMENDED PAYMENT OF FINAL DIVIDEND OF RMB0.03 PER ORDINARY SHARE Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below